Diabetes Mellitus Clinical Trial
— FAITH-DMOfficial title:
Feeding America Intervention Trial for Health--Diabetes Mellitus
| NCT number | NCT02569060 |
| Other study ID # | A125548 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | October 2015 |
| Est. completion date | October 31, 2017 |
| Verified date | May 2020 |
| Source | University of California, San Francisco |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The Feeding America Intervention Trial for Health—Diabetes Mellitus (FAITH-DM) is a randomized, controlled study of the implementation of a diabetes intervention in food pantry settings.
| Status | Completed |
| Enrollment | 568 |
| Est. completion date | October 31, 2017 |
| Est. primary completion date | October 31, 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Food pantry client at one of three participating food banks: Alameda County Community Food Bank (Oakland, CA), Gleaners Community Food Bank of Southeastern Michigan (Detroit, MI), Houston Food Bank, (Houston, TX) - Type II diabetes mellitus with HbA1c = 7.5% using food bank point-of-care testing - Reliable mode of contact (either phone or address) - English or Spanish verbal fluency - 18 years of age or older - Intent to remain in the study area for at least the next 12 months - Willingness to participate in intervention Exclusion Criteria: - Type 1 diabetes - Pregnant or less than 6 weeks post-partum - Cognitively impaired: dementia, mental illness, or active substance abuse severe enough to interfere with administration of the survey or participation in the intervention - Household member already enrolled in the study |
| Country | Name | City | State |
|---|---|---|---|
| United States | Gleaners Community Food Bank of Southeastern Michigan | Detroit | Michigan |
| United States | Houston Food Bank | Houston | Texas |
| United States | Alameda County Community Food Bank | Oakland | California |
| United States | University of California San Francisco | San Francisco | California |
| Lead Sponsor | Collaborator |
|---|---|
| University of California, San Francisco | Feeding America, Laura and John Arnold Foundation, Urban Institute |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Change from Baseline Diabetes Self-Efficacy | 8-item scale of diabetes-specific self-efficacy | 6 months and 12 months | |
| Other | Change from Baseline Diabetes Self-Care | Self-reported assessment of 5 self-care behaviors: medications, exercise, diet, blood sugar monitoring, and foot care | 6 months and 12 months | |
| Primary | Change from Baseline HbA1c at 6 Months | Point-of-care HbA1c testing with the PTS Diagnostics A1CNow®+ System | 6 months | |
| Secondary | Change from Baseline Dietary Intake | Brief fruit & vegetable dietary screener | 6 months and 12 months | |
| Secondary | Change from Baseline Health Care Utilization | Communication with primary care provider requesting dates of service, service levels, and diagnosis codes | 6 months and 12 months | |
| Secondary | Change from Baseline Diabetes Distress | Self-reported distress as assessed by the 2-item emotional burden sub-score of the Diabetes Distress Scale | 6 months and 12 months | |
| Secondary | Change from Baseline Hypoglycemic events | Self-reported hypoglycemic events over the previous 4 weeks, both any events and number of events, and self-reported severe hypoglycemic episodes, both any events and number of events | 6 months and 12 months | |
| Secondary | Change from Baseline Depressive symptoms | PHQ-8 (a subset of PHQ-9 scores without assessment of suicidality) | 6 months and 12 months | |
| Secondary | Change from Baseline Medication Adherence | Morisky Medication Adherence Scale (4 items) | 6 months and 12 months | |
| Secondary | Food vs medicine trade-offs | Three self-reported questions | 6 months and 12 months | |
| Secondary | Change from Baseline Food security status | 6-item version of the USDA's Core Food Security Survey Module | 6 months and 12 months | |
| Secondary | Change from Baseline Food stability | Two items assessing adequacy of food resources to last the entire month | 6 months and 12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |